Canocapavir

DB21570ExperimentalSmall molecule

Canocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor. Canocapavir has a monoisotopic...

Mechanism: Pharmacologically active on Capsid protein
Curator reviewed
Formula / weight: C₂₇H₂₁BrFN₅O₃ · 562.399 g/mol (avg)

Resolves to

Compound

UNIIITF8H4SZR1CAS2137847-19-7ChEMBLCHEMBL5095093ChEBI758676PubChem137477479

Structure

InChIKeyYGPZZDKSASSELG-AREMUKBSSA-NSMILESFC1=CC=C(C=C1)C1=NN(C=C1[C@H]1OCC(=O)N1CCC1=CC=C2NC(=O)NC2=C1)C1=CC=C(Br)C=C1

Targets

P03148C

What you can answer from here — as of October 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Canocapavir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account